NCT00386061View on ClinicalTrials.gov

Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,507

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Obesity
Interventions
DRUG

rimonabant (SR141716)

Trial Locations (7)

08807

Sanofi-Aventis, Bridgewater

Unknown

Sanofi-Aventis, Brussels

Sanofi-Aventis, Helsinki

Sanofi-Aventis, Paris

Sanofi-Aventis, Berlin

Sanofi-Aventis, Gouda

Sanofi-Aventis, Bromma

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00386061 - Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe) | Biotech Hunter | Biotech Hunter